Modulation of N-methyl-D-aspartate receptors by donepezil in rat cortical neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 315, Issue 1, 2005, Pages 125-135

  Moriguchi, Shigeki ^a   Zhao, Xilong ^a   Marszalec, William ^a   Yeh, Jay Z ^a   Narahashi, Toshio ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DONEPEZIL; GUANINE NUCLEOTIDE BINDING PROTEIN; MAGNESIUM ION; N METHYL DEXTRO ASPARTIC ACID; PROTEIN KINASE C;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BATH; BRAIN CELL; CELL POLARITY; COGNITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC POTENTIAL; EMBRYO; ENZYME INHIBITION; EVOKED RESPONSE; FEMALE; LEARNING; LOW DRUG DOSE; MEMORY; NERVE CELL CULTURE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; WHOLE CELL;

ACETYLCHOLINE; ANIMALS; CEREBRAL CORTEX; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GTP-BINDING PROTEINS; INDANS; NEURONS; NOOTROPIC AGENTS; PIPERIDINES; PREGNANCY; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 25644432066     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.105.087908     Document Type: Article

References (35)

1. Aistrup GL, Marszalec W, and Narahashi T (1999) Ethanol modulation of nicotinic acetylcholine receptor currents in cultured cortical neurons. Mol Pharmacol 55:39-49.
2. Ben-Ari Y, Aniksztejn L, and Bregestovski P (1992) Protein kinase C modulation of NMDA currents: an important link for LTP induction. Trends Neurosci 15:333-339.
3. Chen H-SV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, and Lipton SA (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12:4427-4436.
4. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature (Lond) 356:521-523.
5. Collett VJ and Collingridge GL (2004) Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells. Br J Pharmacol 142:991-1001.
6. Collingridge GL and Singer W (1990) Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci 11:290-296.
7. Danysz W and Parsons CG (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int J Geriatr Psychiatry 18:S23-S32.
8. Dingledine R, Borges K, Bowie D, and Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
9. Erkinjuntti T, Roman G, Gauthier S, Feldman H, and Rockwood K (2004) Emerging therapies for vascular dementia and vacular cognitive impairment. Stroke 35:1010-1017.
10. Fonnum F, Myhrer T, Paulsen RE, Wangen K, and Oksengard AR (1995) Role of glutamate and glutamate receptors in memory function and Alzheimer's disease. Ann NY Acad Sci 757:475-486.
11. Francis PT, Sims NR, Procter AW, and Bowen DM (1993) Cortical pyramidal neuron loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives. J Neurochem 60:1589-1604.
12. Giacobini E (2000) Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer's disease. Alzheimer Dis Assoc Disord 14 (Suppl 1):S3-S10.
13. 3H]glutamate binding. J Neurochem 48:543-551.
14. Gu Y and Huang LY (2001) Gabapentin actions on N-methyl-D-aspartate receptor channels are protein kinase C-dependent. Pain 93:85-92.
15. Jann MW, Kaufer DI, and Tariot PN (2002) Alzheimer's Disease: Current Therapeutic Options. A CME/CPE Publication, Oxford Institute for Continuing Education, Inc., New York, NY.
16. Leonard AS and Hell JW (1997) Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites. J Biol Chem 272:12107-12115.
17. Logan SM, Rivera FE, and Leonard JP (1999) Protein kinase C modulation of recombinant NMDA receptor currents: roles for the C-terminal C1 exon and calcium ions. J Neurosci 19:974-986.
18. Maelicke A and Albuquerque EX (2000) Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease. Eur J Pharmacol 393:165-170.
19. Maelicke A, Samochocki M, Jostock R, Fehrenbacher A, Ludwig L, and Albuquerque EX (2001) Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease. Soc Biol Psychiatry 49:279-288.
20. Marszalec W and Narahashi T (1993) Use-dependent pentobarbital block of kainate and quisqualate currents. Brain Res 608:7-15.
21. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, and Seeburg P (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science (Wash DC) 256:1217-1221.
22. Moriguchi S, Marszalec W, Zhao X, Yeh JZ, and Narahashi T (2003a) Alzheimer's drug nefiracetam modulates the activity of NMDA receptors in rat cortical neurons (Abstract). Soc Neurosci 795.12.
23. Moriguchi S, Marszalec W, Zhao X, Yeh JZ, and Narahashi T (2003b) Potentiation N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons. J Pharmacol Exp Ther 307:160-167.
24. Moriguchi S, Marszalec W, Zhao X, Yeh JZ, and Narahashi T (2004a) Donepezil modulates NMDA receptor activity (Abstract). Soc Neurosci 956.8.
25. Moriguchi S, Marszalec W, Zhao X, Yeh JZ, and Narahashi T (2004b) Mechanism action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons. J Pharmacol Exp Ther 310:933-942.
26. Narahashi T, Moriguchi S, Zhao X, Marszalec W, and Yeh JZ (2004) Mechanism action of cognitive enhancers on neuroreceptors. Biol Pharm Bull 27:1701-1706.
27. Ozawa S, Kamiya H, and Tsuzuki K (1998) Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 54:581-618.
28. Palmer AM and Gershon S (1990) Is the neurochemical basis of Alzheimer's disease cholinergic or glutamatergic? FASEB J 4:2745-2752.
29. Palmer AM (1996) Neurochemical studies of Alzheimer's disease. Neurodegeneration 5:381-391.
30. Parsons CG, Danysz W, and Quack G (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 38:735-767.
31. Parsons CG, Gruner R, Rozental J, Millar J, and Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32:1337-1350.
32. Samochocki M, Hoffle A, Fehrenbacher A, Jostock R, Ludwig J, Christner C, Radina M, Zerlin M, Ullmer C, Pereira EFR, et al. (2003) Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not muscarinic acetylcholine receptors. J Pharmacol Exp Ther 305:1024-1036.
33. Schrattenholz A, Pereira EFR, Roth U, Weber KH, Albuquerque EX, and Maelicke (1996) Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol Pharmacol 49:1-6.
34. 3H]MK-801 binding in rat cerebral cortex. Neurosci Lett 272:21-24.
35. Zhao X, Kuryatov A, Lindstorm JM, Yeh JZ, and Narahashi T (2001) Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons. Mol Pharmacol 59:674-683.